Ads
related to: prostate+cancer%2C+cell- nmCRPC Treatment Option
31% Risk of Death Decrease
Visit The Patient Site.
- Dosing & Administration
View Recommended Dosage & Learn
About Drug Interactions Here.
- Clinical Information
Read About A Double-Blind, Placebo-
Controlled, Randomized Study.
- Downloadable Resources
Resources For Physicians & Patients
Available On The Site To Download.
- mHSPC Treatment Option
32% Risk of Death Decrease
Visit The Patient Site.
- Patient Profiles
Explore Patient Profiles To Assess
A Treatment Option.
- nmCRPC Treatment Option
Search results
Statins May Help Prevent Certain Forms of Cancer
Healthline· 3 days agoScientists believe statins, cheap cholesterol-lowering medications, could be used for cancer prevention. Statins have anti-inflammatory effects, which...
BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic...
Digital Journal· 4 days agoPHILADELPHIA and VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology ...
Health & Wellness: Early detection provides pivotal impact in treating skin cancer
Provo Daily Herald· 6 days agoThe statistics on skin cancer are indeed sobering. One in five Americans will be diagnosed with skin...
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1...
Morningstar· 2 days agoNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO ...
Ad
related to: prostate+cancer%2C+cell